Streptococcal–vimentin cross‐reactive antibodies induce microvascular cardiac endothelial proinflammatory phenotype in rheumatic heart disease

• Published in: Clinical and experimental immunology Vol. 173; no. 3; pp. 419 - 429
• Main Authors: Delunardo, F., Scalzi, V., Capozzi, A., Camerini, S., Misasi, R., Pierdominici, M., Pendolino, M., Crescenzi, M., Sorice, M., Valesini, G., Ortona, E., Alessandri, C.
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 01.09.2013; Blackwell Science Inc
• Subjects: Adolescent; Adult; Amino Acid Sequence; Animals; Antibodies - blood; Antibodies - immunology; Antigens; anti‐endothelial cell autoantibodies; Autoantibodies - blood; Autoantibodies - immunology; Autoantigens - immunology; Bacterial Proteins - chemistry; Bacterial Proteins - immunology; Cardiovascular disease; Child; Cross Reactions - immunology; Cytokines; Endocarditis - genetics; Endocarditis - immunology; Endothelium - immunology; Endothelium - metabolism; Female; Genotype & phenotype; Humans; Male; Middle Aged; Molecular Sequence Data; Original; Proteins; Rabbits; rheumatic heart disease; Rheumatic Heart Disease - genetics; Rheumatic Heart Disease - immunology; Rheumatoid Vasculitis - genetics; Rheumatoid Vasculitis - immunology; Streptococcus; Streptococcus - immunology; vimentin; Vimentin - chemistry; Vimentin - genetics; Vimentin - immunology; Young Adult; rheumatic heart disease; anti-endothelial cell autoantibodies; vimentin
• ISSN: 0009-9104; 1365-2249
• DOI: 10.1111/cei.12135

Summary Rheumatic heart disease (RHD) is characterized by the presence of anti‐streptococcal group A antibodies and anti‐endothelial cell antibodies (AECA). Molecular mimicry between streptococcal antigens and self proteins is a hallmark of the pathogenesis of rheumatic fever. We aimed to identify, in RHD patients, autoantibodies specific to endothelial autoantigens cross‐reactive with streptococcal proteins and to evaluate their role in inducing endothelial damage. We used an immunoproteomic approach with endothelial cell‐surface membrane proteins in order to identify autoantigens recognized by AECA of 140 RHD patients. Cross‐reactivity of purified antibodies with streptococcal proteins was analysed. Homologous peptides recognized by serum cross‐reactive antibodies were found through comparing the amino acid sequence of streptococcal antigens with human antigens. To investigate interleukin (IL)‐1R‐associated kinase (IRAK1) and nuclear factor‐κB (NF‐κB) activation, we performed a Western blot analysis of whole extracts proteins from unstimulated or stimulated human microvascular cardiac endothelial cells (HMVEC‐C). Adhesion molecule expression and release of proinflammatory cytokines and growth factors were studied by multiplex bead based immunoassay kits. We observed anti‐vimentin antibodies in sera from 49% RHD AECA‐positive patients. Cross‐reactivity of purified anti‐vimentin antibodies with heat shock protein (HSP)70 and streptopain streptococcal proteins was shown. Comparing the amino acid sequence of streptococcal HSP70 and streptopain with human vimentin, we found two homologous peptides recognized by serum cross‐reactive antibodies. These antibodies were able to stimulate HMVEC‐C inducing IRAK and NF‐κB activation, adhesion molecule expression and release of proinflammatory cytokines and growth factors. In conclusion, streptococcal–vimentin cross‐reactive antibodies were able to activate microvascular cardiac endothelium by amplifying the inflammatory response in RHD.